Abstract
Purpose. The intravenous glucocorticoid (iv GC) represents the mainstay of therapy for Graves' ophthalmopathy (GO), but uncertainty remains concerning......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
